共 50 条
Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors
被引:18
|作者:
Shi, Lei
[1
]
Yang, Ying
[1
]
Li, Zi-Lin
[1
]
Zhu, Zhen-Wei
[1
]
Liu, Chang-Hong
[1
]
Zhu, Hai-Liang
[1
]
机构:
[1] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China
基金:
美国国家科学基金会;
关键词:
Monoamine oxidase;
Inhibitors;
Nicotinamides;
Structure-activity relationship;
Molecular docking;
CRYSTAL-STRUCTURES;
DRUG TARGET;
MAO-B;
BRAIN;
ANTIDEPRESSANTS;
POPULATIONS;
DISEASE;
BINDING;
D O I:
10.1016/j.bmc.2009.12.065
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
A series of N-(2-morpholinoethyl)nicotinamide (1-13) and N-(3-morpholinopropyl)nicotinamide derivatives (14-26) have been designed, synthesized and evaluated in vitro for their monoamine oxidase (MAO) A and B inhibitory activity and selectivity. Most of these synthesized compounds proved to be potent, and selective inhibitors of MAO-A rather than of MAO-B. 5-Chloro-6-hydroxy-N-(2-morpholinoethyl)nicotinamide (13) displayed the highest MAO-A inhibitory potency (IC50 = 0.045 mu M) and a good selectivity. 2-Bromo-N-(2-morpholinoethyl)nicotinamide (3) was the most potent MAO-B inhibitor with the IC50 value of 0.32 mu M, but it was not selective. Molecular dockings of compound 13 were performed in order to give structural insights regarding the MAO-A selectivity. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1659 / 1664
页数:6
相关论文